Navigation Links
Undergoing multiple ACL surgeries allows patients to regain basic function, but not full activity
Date:7/14/2012

This release is also available in Chinese on EurekAlert! Chinese.

BALTIMORE, MD Patients who undergo repeated anterior cruciate ligament (ACL) reconstructions, or repeat revision surgery, are unlikely to return to prior activity levels despite showing basic functional improvement according to research being presented at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting today.

"We focused on 15 patients entering at least their third ACL surgery on the same knee, a rarity in the orthopedic community" noted lead author Diane Dahm, MD, orthopaedic surgeon from the Mayo Clinic. "These patients, ranging in age from 18 to 57, all demonstrated a return to basic function based on a collective increase in IKDC scores from pre-operative levels at 59 to post-operative levels at approximately 80."

The IKDC system allows patients to self-evaluate their post-surgery recovery. The focus group included 15 of the 18 known repeat revision surgery cases between 1998 and 2009, with eight males and seven females. All patients examined in this study reported improved outcomes in day-to-day function after a repeat revision surgery, however only 27 percent had returned to their same preoperative activity level at final follow up. Patients with grade III or IV chondral injuries or BMI greater than 28 had worse functional outcomes.

"While the small number of patients in this study is a limitation," commented Dahm, "the procedure is relatively uncommon and this is the largest to-date. Gathering information on these unique patients is an important step toward understanding how people will function after a repeat ACL surgery."

No immediate post-operative complications were noted during the study.


'/>"/>

Contact: Lisa Weisenberger
lisa@aossm.org
847-655-8647
American Orthopaedic Society for Sports Medicine
Source:Eurekalert

Related medicine news :

1. Scientists uncover multiple faces of deadly breast cancer
2. Experimental Pill for Multiple Sclerosis Shows Promise
3. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
4. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
5. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
6. Multiple thought channels may help brain avoid traffic jams
7. Study shows benefit of new maintenance therapy for multiple myeloma
8. FDA Issues Multiple Sclerosis Drug Alert
9. Pot Might Help Ease Multiple Sclerosis Symptoms
10. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
11. Multiple sclerosis patients have lower risk of cancer: UBC-VCH research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial ... for Graduate Medical Education (ACGME) that it has received accreditation for its residency ... of three residency programs that Memorial is currently pursuing, including Pediatrics and Internal ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... ... April 29, 2016 , ... Spine Team Texas, a ... proud to announce one of their physicians has been invited to be a featured ... ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. Scott ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
(Date:4/29/2016)... ... 29, 2016 , ... Jvion, the market leader in clinical ... Eastside Partners, with participation from existing investor Martin Ventures. The funds will ... technology and product roadmap. , “Jvion is experiencing significant growth and ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
(Date:4/27/2016)... Conn. , April 27, 2016   ... of its digital health technology platform, which specializes ... and programs into scalable digital products, Zillion enables ... engagement and empower consumers to take control of ... face-to-face live video conferencing – including one-to-one, group ...
Breaking Medicine Technology: